Market
How will major healthcare providers respond to prenatal blood tests for cancer detection by end of 2025?
2
Resolution / Starting Odds
Full endorsement • 25%
Conditional endorsement • 25%
No endorsement • 25%
Opposition • 25%
Press releases or official statements from major healthcare providers
Story
NEJM Study: Prenatal Blood Test May Detect Hidden Cancers in 1 in 2 Pregnant Women
Dec 5, 2024, 11:45 AM
A study published in the New England Journal of Medicine (NEJM) has revealed that prenatal blood tests, specifically cell-free DNA (cfDNA) sequencing for fetal aneuploidy, can sometimes indicate the presence of hidden cancers in pregnant women. The IDENTIFY study found that among 107 participants with unusual or nonreportable results from these tests, approximately half were diagnosed with an occult cancer. Most of the genetic variants detected were copy number variations (CNVs) across multiple chromosomes. The study was conducted by commercial laboratories in North America and highlights the potential of prenatal testing to alert healthcare providers to maternal health issues beyond fetal conditions.
View original story
Similar markets
Mayo Clinic • 25%
Cleveland Clinic • 25%
None of these • 25%
Kaiser Permanente • 25%
USA • 25%
Other • 25%
Germany • 25%
UK • 25%
No • 50%
Yes • 50%
Criticize or oppose • 25%
Neutral stance • 25%
Support and endorse • 25%
No official response • 25%
Public condemnation only • 25%
Increased security measures • 25%
Policy changes or reforms • 25%
No significant reaction • 25%